NHS England Innovation & Technology Tariff
At the start of November 2016, NHS England set out plans to fast-track the introduction of six new types of medical technology products and apps during 2017/18 through the Innovation and Technology Tariff (ITT). The ITT removes the need for multiple local price negotiations and guarantees automatic reimbursement.
For five of the above, NHS England will centrally pick up the costs where these have been incurred in line with requirements about use. The sixth innovation is an alternative to existing surgical procedures, and is already funded as part of tariff calculations.
The ITT innovations are:
- Episcissors 60- a guided mediolateral episiotomy tool to minimise the risk of obstetric anal sphincter injury
- Non-injectable arterial connector (NIC) – Arterial connecting systems to reduce bacterial contamination and the accidental administration of medication
- Pnuex – Pneumonia prevention systems which are designed to stop ventilator-associated pneumonia
- myCOPD- a web based application for the self-management of chronic obstructive pulmonary disease (COPD)
- Frozen Faecal microbiota transplantation (FMT) – for recurrent Clostridium difficile infection rates
- Urolift – for management of Benign prostatic hyperplasia as a day case (purchased through National Tariff)
Separately from the tariff, NHS England is centrally funding the purchase of mobile ECG technology, which will be managed through the AHSN Network.
The ITT went live on 1 April 2017 and NHS England is keen to encourage the adoption and spread of these technologies. You can find out more about procuring NIA innovations via the ITT here.